Selection of Optimal κB/Rel DNA-Binding Motifs: Interaction of Both Subunits of NF-κB with DNA Is Required for Transcriptional Activation

REFERENCES

• Baeuerle, P. 1991. The inducible transcription activator NF-κB: regulation by distinct protein subunits. Biochem. Biophys. Res. Commun. 1072: 63–80.
   Google Scholar
• Baeuerle, P. A., and D. Baltimore. 1989. A 65 kD subunit of active NF-κB is required for inhibition of NF-κB. Genes Dev. 3: 1689–1698.
   PubMed Web of Science ®Google Scholar
• Baeuerle, P. A., and D. Baltimore. 1991. The physiology of the NF-κB transcription factor. Mol. Aspects Cell. Regul. 6: 409–432.
   Google Scholar
• Baldwin, A. S., and P. A. Sharp. 1987. Binding of a nuclear factor to a regulatory sequence in the promoter of the mouse H-2Kb class I major histocompatibility gene. Mol. Cell. Biol. 7: 305–313.
   PubMed Web of Science ®Google Scholar
• Ballard, D., E. Dixon, N. Peffer, H. Bogerd, S. Doerre, B. Stein, and W. Greene. 1992. The 65-kDa subunit of human NF-κB functions as a potent transcriptional activator and a target for v-Rel-mediated repression. Proc. Natl. Acad. Sci. USA 89: 1875–1879.
   PubMedGoogle Scholar
• Ballard, D. W., W. H. Walker, S. Doerre, P. Sisra, J. A. Molitor, E. P. Dixon, N. J. Peffer, M. Hannink, and W. C. Greene. 1990. The v-rel oncogene encodes a kB enhancer binding protein that inhibits NF-κB function. Cell 63: 803–814.
   PubMed Web of Science ®Google Scholar
• Bours, V., J. Villalobos, P. R. Burd, K. Kelly, and U. Sienbenlist. 1990. Cloning of a mitogen-inducible gene encoding a kB DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs. Nature (London) 348: 76–79.
   PubMed Web of Science ®Google Scholar
• Collart, M., P. Baeuerle, and P. Vassalli. 1990. Regulation of tumor necrosis factor α transcription in macrophages: involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB. Mol. Cell. Biol. 10: 1498–1506.
   PubMed Web of Science ®Google Scholar
• Duyao, M., A. Buckler, and G. Sonenshein. 1990. Interaction of an NF-κB like factor with a site upstream of the c-myc promoter. Proc. Natl. Acad. Sci. USA 87: 4727–4731.
   PubMed Web of Science ®Google Scholar
• Edbrooke, M., D. Burt, J. Cheshire, and P. Woo. 1989. Identification of cis-acting sequences responsible for phorbol ester induction of human serum amyloid a gene expression via a nuclear factor κB-like transcription factor. Mol. Cell. Biol. 9: 1908–1916.
   PubMed Web of Science ®Google Scholar
• Fujita, T., G. Nolan, S. Ghosh, and D. Baltimore. 1992. Independent modes of transcriptional activation by the p50 and p65 subunits of NF-κB. Genes Dev. 6: 775–787.
   PubMed Web of Science ®Google Scholar
• Gentz, R., C. H. Chen, and C. A. Rosen. 1989. Bioassay for trans-activation using purified human immunodeficiency virus tat-encoded protein: trans-activation requires mRNA synthesis. Proc. Natl. Acad. Sci. USA 86: 821–824.
   PubMedGoogle Scholar
• Ghosh, S., A. M. Gifford, L. B. Riviere, P. Tempst, G. P. Nolan, and D. Baltimore. 1990. Cloning of the p50 DNA binding subunit of NF-κB: homology to rel and dorsal. Cell 62: 1019–1029.
   PubMed Web of Science ®Google Scholar
• Gilmore, T. D. 1990. NF-κB, KBF1, dorsal, and related matters. Cell 62: 841–843.
   PubMed Web of Science ®Google Scholar
• Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2: 1044–1051.
   PubMed Web of Science ®Google Scholar
• Hansen, S., C. Nerlov, U. Zabel, P. Verde, M. Johnsen, P. Baeuerle, and F. Blasi. 1992. A novel complex between the p65 subunit of NF-κB and c-Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase gene. EMBO J. 11: 205–213.
   PubMed Web of Science ®Google Scholar
• Ho, S., H. Hunt, R. Horton, J. Pullen, and L. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77: 51–59.
   PubMed Web of Science ®Google Scholar
• Inoue, J.-I., L. D. Kerr, L. J. Ransone, E. Bengal, T. Hunter, and I. M. Verma. 1991. c-rel activates but v-rel suppresses transcription from kB sites. Proc. Natl. Acad. Sci. USA 88: 3715–3719.
   PubMedGoogle Scholar
• Ip, Y. T., R. Kraut, M. Levine, and C. Rushlow. 1991. The dorsal morphogen is a sequence-specific DNA-binding protein that interacts with a long-range repression element in Drosophila. Cell 64: 439–446.
   PubMedGoogle Scholar
• Israel, A., O. LeBail, D. Hata, J. Piette, M. Kieran, F. Logeat, D. Wallach, M. Fellous, and P. Kourilsky. 1989. TNF stimulates expression of mouse MHC class I genes by inducing an NF-κB like enhancer binding activity which displaces constitutive factors. EMBO J. 8: 3793–3800.
   PubMedGoogle Scholar
• Kawakami, K.-T., C. Scheidereit, and R. G. Roeder. 1988. Identification and purification of a human immunoglobulin- enhancer-binding protein (NF-κB) that activates transcription from a human immunodeficiency virus type I promoter in vitro. Proc. Natl. Acad. Sci. USA 84: 4700–4704.
   Google Scholar
• Kieran, M., V. Blank, F. Logeat, J. Vandekerchove, F. Lott- speich, O. LeBail, M. B. Urban, P. Kourilsky, P. A. Baeuerle, and A. Israel. 1990. The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product. Cell 62: 1007–1018.
   PubMed Web of Science ®Google Scholar
• Klement, J. F., and C. A. Rosen. Unpublished data.
   Google Scholar
• Kolodziej, P. A., and R. A. Young. 1991. Epitope tagging and protein surveillance. Methods Enzymol. 194: 508–519.
   PubMed Web of Science ®Google Scholar
• Kretzschmar, M., M. Meisterernst, C. Scheidereit, G. Li, and R. Roeder. 1992. Transcriptional regulation of the HIV-1 promoter by NF-κB in vitro. Genes Dev. 6: 761–774.
   PubMed Web of Science ®Google Scholar
• Lenardo, M. J., and D. Baltimore. 1989. NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58: 227–229.
   PubMed Web of Science ®Google Scholar
• Lilenbaum, A., M. Dodon, C. Alexandre, L. Gazzolo, and D. Paulin. 1990. Effect of human T-cell leukemia virus type I tax protein on activation of the human vimentin gene. J. Virol. 64: 256–263.
   PubMedGoogle Scholar
• Logeat, F., N. Israel, R. Ten, V. Blank, O. Le Bail, P. Kourilsky, and A. Israel. 1991. Inhibition of transcription factors belonging to the rel/NF-κB family by a trans-dominant negative mutant. EMBO J. 10: 1827–1832.
   PubMed Web of Science ®Google Scholar
• Mavrothalassitis, G., G. Beal, and T. Papas. 1990. Defining target sequences of DNA-binding proteins by random selection and PCR: determination of the GCN4 binding sequence repertoire. DNA Cell Biol. 9: 783–788.
   PubMedGoogle Scholar
• McDonnell, P., S. Kumar, A. Rabson, and C. Gelinas. 1992. Transcriptional activity of rel family proteins. Oncogene 7: 163–170.
   PubMedGoogle Scholar
• Mukaida, N., M. Shiroo, and K. Matsushima. 1989. Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J. Immunology 143: 1366–1371.
   PubMed Web of Science ®Google Scholar
• Naar, A., J.-M. Boutin, S. Lipkin, V. Yu, J. Holloway, C. Glass, and M. Rosenfeld. 1991. The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors. Cell 65: 1267–1279.
   PubMed Web of Science ®Google Scholar
• Nabel, G., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (London) 326: 711–713.
   PubMed Web of Science ®Google Scholar
• Narayanan, R., J. F. Klement, S. M. Ruben, K. A. Higgins, and C. A. Rosen. 1992. Identification of a naturally occurring transforming variant of the transcription factor NF-κB. Science 256: 367–370.
   PubMedGoogle Scholar
• Nolan, G. P., S. Ghosh, H.-C. Liou, P. Tempst, and D. Baltimore. 1991. DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide. Cell 64: 961–969.
   PubMed Web of Science ®Google Scholar
• Pessara, U., and N. Koch. 1990. Tumor necrosis factor a regulates expression of the major histocompatibility complex class Il-associated invariant chain by binding of an NF-κB-like factor to a promoter element. Mol. Cell. Biol. 10: 4146–4154.
   PubMedGoogle Scholar
• Pollock, R., and R. Treisman. 1990. A sensitive method for the determination of protein-DNA binding specificities. Nucleic Acids Res. 18: 6197–6204.
   PubMed Web of Science ®Google Scholar
• Pollock, R., and R. Treisman. 1991. Human SRF-related proteins: DNA-binding properties and potential regulatory targets. Genes Dev. 5: 2327–2341.
   PubMed Web of Science ®Google Scholar
• Queen, C., and D. Baltimore. 1983. Immunoglobulin gene transcription is activated by downstream sequence elements. Cell 33: 741–748.
   PubMed Web of Science ®Google Scholar
• Ron, D., A. Brasier, K. Wright, J. Tate, and J. Habener. 1990. An inducible 50-kilodalton NF-κB-like protein and a constitutive protein both bind the acute-phase response element of the angiotensinogen gene. Mol. Cell. Biol. 10: 1023–1032.
   PubMedGoogle Scholar
• Rosen, C. A., J. G. Sodroski, and W. A. Haseltine. 1985. The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell 41: 813–823.
   PubMedGoogle Scholar
• Ruben, S., J. Klement, T. Coleman, M. Maher, C.-H. Chen, and C. Rosen. 1992. I-Rel: a novel reZ-related protein that inhibits NF-κB transcriptional activity. Genes Dev. 6: 745–760.
   PubMedGoogle Scholar
• Ruben, S. M., P. J. Dillon, R. Schreck, T. Henkel, C.-H. Chen, M. Maher, P. A. Baeuerle, and C. A. Rosen. 1991. Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-κB. Science 251: 1490–1493.
   PubMedGoogle Scholar
• Ruben, S. M., R. Narayanan, J. F. Klement, C.-H. Chen, and C. Rosen. 1992. Functional characterization of the NF-κB p65 transcriptional activator and an alternatively spliced derivative. Mol. Cell. Biol. 12: 444–454.
   PubMedGoogle Scholar
• Ryseck, R. P., P. Bull, M. Takamiya, V. Bours, U. Siebenlist, P. Dobrzanski, and R. Bravo. 1992. Rel B, a new Rel family transcription activator that can interact with DNA. Mol. Cell. Biol. 12: 674–684.
   PubMedGoogle Scholar
• Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74: 5463–5467.
   PubMed Web of Science ®Google Scholar
• Schmitz, M. L., and P. A. Baeuerle. 1991. The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J. 10: 3805–3817.
   PubMed Web of Science ®Google Scholar
• Sen, R., and D. Baltimore. 1986. Inducibility of k immunoglobulin enhancer-binding protein NF-κB by a post-translational mechanism. Cell 47: 921–928.
   PubMed Web of Science ®Google Scholar
• Sen, R., and D. Baltimore. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46: 705–716.
   PubMed Web of Science ®Google Scholar
• Sica, A., T.-H. Tan, N. Rice, M. Kretzschmar, P. Ghosh, and H. Young. 1992. The c-rel proto-oncogene product c-Rel but not NF-κB binds to the intronic region of the human interferon-γ gene at a site related to an interferon-stimulable response element. Proc. Natl. Acad. Sci. USA 89: 1740–1744.
   PubMed Web of Science ®Google Scholar
• Urban, M., and P. Baeuerle. 1991. The role of the p50 and p65 subunits of NF-κB in the recognition of cognate sequences. New Biol. 3: 279–288.
   PubMedGoogle Scholar
• Urban, M., R. Schreck, and P. Baeuerle. 1991. NF-κB contacts DNA by a heterodimer of the p50 and p65 subunit. EMBO J. 10: 1817–1825.
   PubMed Web of Science ®Google Scholar
• Urban, M. B., and P. A. Baeuerle. 1990. The 65-kD subunit of NF-κB is a receptor for IκB and a modulator of DNA-binding specificity. Genes Dev. 4: 1975–1984.
   PubMedGoogle Scholar